Sphera Funds Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Sphera Funds Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-216,980	Closed	-$4.78M	–	211
2020 Q4	$4.78M	Buy	216,980 +17,000	+9%	+$374K	0.42%	69
2020 Q3	$3.6M	Buy	+199,980	New	+$4.14M	0.35%	68
2019 Q4	–	Sell	-565,000	Closed	-$8.11M	–	102
2019 Q3	$8.11M	Buy	565,000 +250,358	+80%	+$3.58M	1.25%	18
2019 Q2	$4.96M	Buy	+314,642	New	+$4.28M	0.68%	41
2015 Q1	–	Sell	-176,802	Closed	-$2.91M	–	172
2014 Q4	$2.91M	Buy	+176,802	New	+$2.04M	0.5%	67

Other funds holding DRNA

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Sphera Funds Management's DRNA Position: Q1 2021 in Review

Sphera Funds Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q1 2021, closing a stake of 216,980 shares — an estimated $4.78M sold.

Sphera Funds Management first reported a position in DRNA in Q4 2014 and held it in 5 quarters. The position peaked at $8.11M in Q3 2019. 183 funds tracked by Wall St. Rank hold DRNA as of Q1 2021.

Sphera Funds Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
Sphera Funds Management sold 216,980 Dicerna Pharmaceuticals, Inc. shares in Q1 2021, an estimated $4.78M.
Sphera Funds Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2014 and held it in 5 quarters.
Sphera Funds Management's Dicerna Pharmaceuticals, Inc. position peaked at $8.11M in Q3 2019.
183 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q1 2021.

Based on Sphera Funds Management's 13F filing for Q1 2021, filed 17 May 2021.